510(k) device
0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe
Becton, Dickinson and Company · Saline, Vascular Access Flush (NGT, Class II) · First FDA decision Jul 25, 2014, newest Dec 2, 2025Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
353
Naming "0.9 Sodium Chloride"
MAUDE reports
91
Brand "0.9 Sodium Chloride", since 2015
PubMed studies
2,274
Mentioning "0.9 Sodium Chloride"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
K250884 · Decided Dec 2, 2025 · 253 days after receipt
Device type: Saline, Vascular Access Flush (NGT) · Hospital Medicine & Nursing
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "0.9 Sodium Chloride", any status and sponsor, newest update first.
Saglik Bilimleri UniversitesiAcademic, hospital or other
NCT07937683 · 90 participants · Start May 1, 2021 · Primary completion Oct 14, 2022
Device: Occlusal Splint · For: Myofascial Pain - Dysfunction Syndrome of TMJ; Bruxism
Sites: Ankara, Turkey (Türkiye)
352 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "0.9 Sodium Chloride", and for the whole product code for context.
This brand
91 reports: 68 malfunction, 16 injury, 3 death
Whole product code NGT
3,043 reports: 2,791 malfunction, 207 injury, 23 death
Newest reports for this brand
MW6002889 · Received Sep 24, 2026
Device type: Saline, Vascular Access Flush (NGT)
Device problem as coded: Defective Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- PosiFlush Prefilled Saline Syringe with General Pump Compatibility (10mL Syringe with 10mL Saline Fill), Catalog Number 306547Open, Classified
Z-0736-2024 · Started Nov 16, 2023 · Posted by FDA Jan 17, 2024
Reason given: An incorrect stopper was used in nine lots of 10mL BD PosiFlush Normal Saline Flush Syringes with General Pump Compatibility. The use of BD PosiFlush Prefilled Flush Syringes with this stopper causes an increase in injection force, which has the potential to trigger alarms if used with a syringe pump.
Cause as FDA categorized it: Under Investigation by firm · Device type: Saline, Vascular Access Flush (NGT)
3 more recall records with a free account
Published research
The most relevant PubMed records for "0.9 Sodium Chloride"[tiab]. The summary above synthesizes these.
- Fluid therapy in diabetic ketoacidosis.
Ramanan M, Delaney A, Venkatesh B · Curr Opin Clin Nutr Metab Care · 2024Review, Research Support, Non-U.S. Gov't
- Resuscitation fluids.
Casey JD, Brown RM, Semler MW · Curr Opin Crit Care · 2018Research Support, Non-U.S. Gov't, Review
- Exercise-induced anaphylaxis.
Shimizu T, Tokuda Y · BMJ Case Rep · 2012Case Reports
- Normal saline: Past, present, and future.
Liu X, Lu M · Sci Prog · 2023Review
- 0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU-a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial.
Raman S, Schibler A, Marsney RL, et al. · Trials · 2021Clinical Trial Protocol
- Heparin versus 0.9% sodium chloride intermittent flushing for preventing occlusion in newborns with peripherally inserted central catheters: A systematic review protocol.
Nascimento APD, de Medeiros KS, Costa APF, et al. · PLoS One · 2022
- Balanced Crystalloid versus 0.9% Sodium Chloride: What We Overlook in Our Research.
Kasatkin A, Urakov A, Nigmatullina A, et al. · Anesthesiology · 2021Comparative Study
- Serum chloride concentration and outcomes in adults receiving intravenous fluid therapy with a balanced crystalloid solution or 0.9% sodium chloride.
Ramanan M, Hammond N, Billot L, et al. · Intensive Care Med · 2025Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- 0.9% sodium chloride versus ringer's lactate in the management of severe diabetic ketoacidosis: A randomized trial.
Trifi A, Ben Braik I, Galai H, et al. · Med Intensiva (Engl Ed) · 2026Randomized Controlled Trial, Comparative Study
- Assessing pharmacist competency after hurricane-related shortages of 0.9% sodium chloride injection.
Kisch GL · Am J Health Syst Pharm · 2019Letter
- Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution.
Guo Z, Chen P, Liu L, et al. · Medicine (Baltimore) · 2022
- Is levomepromazine stable over time?
Hardy J, O'Shea A, Gilbert C, et al. · Palliat Med · 2011Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code NGT.
- Praxiject 0.9% NaClMedxl, Inc. · 510(k) 2023
- AMSafe Pre-Filled Normal Saline Flush SyringeAmsino International, Inc. · 510(k) 2022
- 0.9% Sodium Chloride Injection, USP, Pre-filled COP SyringeMedline Industries, Inc. · 510(k) 2019
- 0.9% Sodium Chloride Flush SyringeAm USA · 510(k) 2014
- 0.9% Sodium Chloride Injection Usp Bd Posiflush Flush Syringe, Sf Flush SyringeBecton, Dickinson & CO · 510(k) 2013
- Am Usa 0.9% Sodium Chloride Flush SyringeAm USA · 510(k) 2012
- Medefil's Normal Saline I.v. Flush SyringeMedefil, Inc. · 510(k) 2010
- Praxiject SP 0.9% NaClMedxl, Inc. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.